Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Total Non-current Assets
All assets not expected to be converted to cash within one year.
Beta Bionics, Inc.NASDAQ: BBNX
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets falls 25.9% from a year ago
Total non-current assets stood at $56.43M at the end of Q1 FY2026, down 25.9% from a year earlier and down 7.2% from the prior quarter. Over 3 fiscal years it compounded at +105.0% a year.
Context
- Total non-current assets amounted to 18.5% of total assets at the end of Q1 FY2026, down 4.0 pp from a year earlier.
- Total non-current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps falling in the next quarterly balance sheet after a -25.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 60.84M USD
- Year-over-year change
- +263.8%
- 3-year CAGR
- +105.0%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 60.84M | +263.8% |
| FY2024 | 2024-12-31 | 16.72M | +160.5% |
| FY2023 | 2023-12-31 | 6.42M | -9.1% |
| FY2022 | 2022-12-31 | 7.06M | — |
Total Non-current Assets vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -25.9% is the lowest of 7, against a peer median of +14.7%.
- Total non-current assets amounts to 18.5% of total assets for BBNX, versus a peer median of 64.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 386.25B DKK | +20.9% | +40.7% | 64.9% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $3.3B USD | — | — | 70.0% |
| Jun 2026 | $2.37B USD | +3.1% | +10.2% | 36.7% | |
| Jun 2026 | $1.32B USD | +8.6% | +11.0% | 41.6% | |
| Mar 2026 | $493.24M USD | +261.6% | +102.4% | 66.3% | |
| Mar 2026 | $266.29M USD | +2.9% | +9.0% | 23.1% | |
| Mar 2026 | $200.7M USD | +1149.4% | +178.2% | 74.7% | |
| Mar 2026 | $56.43M USD | -25.9% | +105.0% | 18.5% | |
| Peer median (excluding BBNX) | — | +14.7% | +25.8% | 64.9% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.